Perspective Therapeutics (CATX) Price & Analysis

Compare

1,508 Followers

CATX Stock Chart & Stats

$2.19

-$0.13(-3.36%)

At close: Jan 08 4:00 PM EST

$2.19

-$0.13(-3.36%)

Day’s Range― - ―

52-Week Range$1.60 - $11.83

Previous CloseN/A

Volume311.62K

Average Volume (3M)1.43M

Market Cap

$173.03M

Enterprise Value$67.36M

Total Cash (Recent Filing)$191.58M

Total Debt (Recent Filing)$1.92M

Price to Earnings (P/E)―

Beta1.20

Next Earnings

Nov 18, 2025

EPS Estimate

-0.32

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.30

Shares Outstanding74,262,990

10 Day Avg. Volume1,251,069

30 Day Avg. Volume1,427,150

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)0.71

Price to Sales (P/S)0.00

P/FCF Ratio-2.83

Enterprise Value/Market Cap0.39

Enterprise Value/Revenue116.94

Enterprise Value/Gross Profit-77.87

Enterprise Value/Ebitda-0.57

Forecast

1Y Price Target

$13.10

Price Target Upside498.17% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering10

EPS Forecast (FY)-1.19

Revenue Forecast (FY)$1.13M

Bulls Say, Bears Say

Bulls Say

Platform PotentialFavorable data from Pb-212-based assets is viewed as positive for CATX due to the company's focus on its Pb-212-based platform.

Product ExpansionThe company is evaluating a potential expansion into other SSTR2 tumor types, such as breast and small cell lung cancer.

Safety ProfileVMT-α-NET has a potentially better safety profile, with a lower rate of grade 3+ treatment-emergent adverse events compared to AlphaMedix.

Bears Say

Development CompetitionPerspective Therapeutics is currently behind in development compared to Sanofi, as Sanofi plans a phase 3 trial for its competing product.

Efficacy ComparisonThe objective response rate (ORR) of 44% for VMT-α-NET falls below previous results and the higher bar set by competitor AlphaMedix, which reported a 60% ORR.

Market ReactionCATX stock is down ~26% following updated data for the VMT-a-NET program in NETs at the ESMO conference.

Perspective Therapeutics News

Perspective Therapeutics falls after update on Phase 1/2a trial

Shares of Perspective Therapeutics (CATX) are down $1.52, or 34%, to $2.97 after the radiopharmaceutical company announced that...

19d ago

CATX

Perspective Therapeutics initiated with a Buy at BTIG

BTIG analyst Jeet Mukherjee initiated coverage of Perspective Therapeutics (CATX) with a Buy rating and $14 price target...

30d ago

CATX

Perspective Therapeutics Updates Corporate Presentation on Pipeline

Perspective Therapeutics ( ($CATX) ) has issued an update. On November 6, 2025, Perspective Therapeutics updated its corporate...

3d ago

CATX

Perspective Therapeutics Updates Executive Employment Agreements

An announcement from Perspective Therapeutics ( ($CATX) ) is now available. On November 3, 2025, Perspective Therapeutics, Inc....

5d ago

CATX

Perspective Therapeutics Advances in Neuroendocrine Tumor Therapy with Promising Clinical Study

Perspective Therapeutics, Inc. (($CATX)) announced an update on their ongoing clinical study. Perspective Therapeutics, Inc. is conducting a...

12d ago

CATX

Perspective Therapeutics Advances Cancer Treatment with Innovative Clinical Study

Perspective Therapeutics, Inc. (($CATX)) announced an update on their ongoing clinical study. Perspective Therapeutics, Inc. (CATX) is conducting...

12d ago

CATX

Perspective Therapeutics’ Innovative Melanoma Trial: A Potential Game-Changer

Perspective Therapeutics, Inc. (($CATX)) announced an update on their ongoing clinical study. Perspective Therapeutics, Inc. is conducting a...

12d ago

CATX

Hold Rating for Perspective Therapeutics Amid Efficacy Concerns and Competitive Challenges

Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Perspective Therapeutics, retaining the price...

19d ago

CATX

Positive Outlook on Perspective Therapeutics Amidst Challenges: Buy Rating Reiterated with $14 Target

Analyst Jeet Mukherjee of BTIG reiterated a Buy rating on Perspective Therapeutics, retaining the price target of $14.00....

19d ago

CATX

Positive Long-Term Outlook for Perspective Therapeutics Despite Mixed ORR Results

In a report released today, Oliver McCammon from LifeSci Capital maintained a Buy rating on Perspective Therapeutics, with...

20d ago

CATX

Perspective Therapeutics Shows Promising Trial Results at ESMO

Perspective Therapeutics ( ($CATX) ) has issued an update. Perspective Therapeutics presented updated interim results from its ongoing...

20d ago

CATX

Positive Buy Rating for Perspective Therapeutics Driven by Promising Clinical Progress and Market Potential of FAP-Targeted Therapy

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Perspective Therapeutics, with...

1M ago

CATX

Perspective Therapeutics announces first patient treated with PSV359

Perspective Therapeutics (CATX) announced that the first patient was treated with 212Pb PSV359 in a second cohort of...

1M ago

CATX

Oppenheimer more confident Perspective’s VMT update will build on prior results

Oppenheimer reiterated an Outperform rating and $14 price target on Perspective Therapeutics (CATX) after the firm hosted the...

2M ago

CATX

CATX FAQ

What was Perspective Therapeutics’s price range in the past 12 months?

Perspective Therapeutics lowest stock price was $1.60 and its highest was $11.83 in the past 12 months.

What is Perspective Therapeutics’s market cap?

Perspective Therapeutics’s market cap is $173.03M.

When is Perspective Therapeutics’s upcoming earnings report date?

Perspective Therapeutics’s upcoming earnings report date is Nov 18, 2025 which is in 9 days.

How were Perspective Therapeutics’s earnings last quarter?

Perspective Therapeutics released its earnings results on Aug 13, 2025. The company reported -$0.3 earnings per share for the quarter, missing the consensus estimate of -$0.293 by -$0.007.

Is Perspective Therapeutics overvalued?

According to Wall Street analysts Perspective Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Perspective Therapeutics pay dividends?

Perspective Therapeutics does not currently pay dividends.

What is Perspective Therapeutics’s EPS estimate?

Perspective Therapeutics’s EPS estimate is -0.32.

How many shares outstanding does Perspective Therapeutics have?

Perspective Therapeutics has 74,262,990 shares outstanding.

What happened to Perspective Therapeutics’s price movement after its last earnings report?

Perspective Therapeutics reported an EPS of -$0.3 in its last earnings report, missing expectations of -$0.293. Following the earnings report the stock price went down -4.271%.

Which hedge fund is a major shareholder of Perspective Therapeutics?

Currently, no hedge funds are holding shares in CATX

Perspective Therapeutics Stock Smart Score

Neutral

Fundamentals

Return on Equity

-31.45%

Trailing 12-Months

Asset Growth

-19.48%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Perspective Therapeutics

Perspective Therapeutics (CATX) is a biotechnology company focused on developing innovative therapeutic solutions within the healthcare sector. The company specializes in the research, development, and commercialization of cutting-edge treatments aimed at addressing complex medical conditions. Their core products and services include advanced therapeutics and technologies designed to improve patient outcomes and enhance the effectiveness of existing treatment regimens.

Perspective Therapeutics (CATX) Earnings & Revenues

Historic Earnings Reports

CATX Stock 12 Month Forecast

Average Price Target

$13.10

▲(498.17% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","19":"$19","4.75":"$4.75","9.5":"$9.5","14.25":"$14.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.1,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$13.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4.75,9.5,14.25,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.73,3.9046153846153846,5.079230769230769,6.253846153846154,7.428461538461539,8.603076923076923,9.777692307692307,10.952307692307693,12.126923076923077,13.301538461538462,14.476153846153846,15.650769230769232,16.825384615384614,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.73,3.5276923076923077,4.325384615384615,5.123076923076923,5.92076923076923,6.718461538461538,7.516153846153845,8.313846153846153,9.11153846153846,9.909230769230769,10.706923076923076,11.504615384615384,12.302307692307691,{"y":13.1,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.73,2.9046153846153846,3.079230769230769,3.253846153846154,3.4284615384615384,3.603076923076923,3.7776923076923077,3.9523076923076923,4.126923076923077,4.3015384615384615,4.476153846153846,4.650769230769231,4.825384615384616,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.8,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.63,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.09,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.19,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.78,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.96,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.47,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.39,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.28,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.68,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.32,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.43,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.73,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >